KOREA UNITED PHARM INC
033270 | KO
Overview
Corporate Details
- ISIN(s):
- KR7033270000
- LEI:
- Country:
- South Korea
- Address:
- 세종특별자치시 전동면 노장리 404-10, 세종특별자치시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-18 00:00 |
Regulatory Filings
[기재정정]투자판단관련주요경영사항
|
Korean | 18.9 KB | ||
| 2025-09-09 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.0 KB | ||
| 2025-09-09 00:00 |
Regulatory Filings
투자판단관련주요경영사항
|
Korean | 10.6 KB | ||
| 2025-08-28 00:00 |
Regulatory Filings
투자판단관련주요경영사항
|
Korean | 8.2 KB | ||
| 2025-08-13 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1009.4 KB | ||
| 2025-07-28 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.2 MB | ||
| 2025-07-28 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-06-25 00:00 |
Transaction in Own Shares
신탁계약에의한취득상황보고서
|
Korean | 20.2 KB | ||
| 2025-06-18 00:00 |
Report Publication Announcement
기업설명회(IR)개최(안내공시)
|
Korean | 6.1 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1010.9 KB | ||
| 2025-04-29 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-04-22 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 58.4 KB | ||
| 2025-04-22 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2025-04-22 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 159.6 KB | ||
| 2025-03-25 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 15.5 KB |
Automate Your Workflow. Get a real-time feed of all KOREA UNITED PHARM INC filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for KOREA UNITED PHARM INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KOREA UNITED PHARM INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
United Kingdom
ANAN
Türkiye
ANGEN
Developing precision therapeutics for neurodegenerative and CNS disorders.
United States of America
AVXL
United States of America
AVXL
Develops and supplies in vitro diagnostic solutions for human and veterinary markets.
United States of America
NNNN
United States of America
NNNN
Clinical-stage biotech developing an antidote for acute cannabinoid intoxication in ER patients.
United States of America
ANEB
United States of America
ANEB
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan
4563
Japan
4563
Develops joint preservation and regenerative solutions for early intervention orthopedic care.
United States of America
ANIK
United States of America
ANIK
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom
ANCR
United Kingdom
ANCR
Develops, manufactures, and markets branded/generic drugs and OTCs for niche therapeutic areas.
United States of America
ANIP
United States of America
ANIP
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden
ANNX
Sweden
ANNX